BioXcel Therapeutics (BTAI) Return on Capital Employed Growth (1y) (2019 - 2026)
BioXcel Therapeutics (BTAI) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 1,195.00 |
| 10 | BioXcel Therapeutics | 20.39 Mn | 20.39 Mn | -77,000.00 | 73,792.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73,792.00 |
| Dec 31, 2025 | 87,072.00 |
| Sep 30, 2025 | 225,843.00 |
| Jun 30, 2025 | 455,212.00 |
| Mar 31, 2025 | -10,099.00 |
| Dec 31, 2024 | -2,727.00 |
| Sep 30, 2024 | 1,082.00 |
| Jun 30, 2024 | -7,935.00 |
| Mar 31, 2024 | -20,185.00 |
| Dec 31, 2023 | -20,426.00 |
| Sep 30, 2023 | -19,371.00 |
| Jun 30, 2023 | -9,837.00 |
| Mar 31, 2023 | -5,568.00 |
| Dec 31, 2022 | -3,721.00 |
| Sep 30, 2022 | -1,984.00 |
| Jun 30, 2022 | -1,384.00 |
| Mar 31, 2022 | -619.00 |
| Dec 31, 2021 | -792.00 |
| Sep 30, 2021 | 1,064.00 |
| Jun 30, 2021 | 4,336.00 |